ErbB3 (HER3) interaction with the p85 regulatory subunit of phosphoinositide 3-kinase. - Wikidata - awgldk - TriplyDB

ErbB3 (HER3) interaction with the p85 regulatory subunit of phosphoinositide 3-kinase.

ErbB3 (HER3) interaction with the p85 regulatory subunit of phosphoinositide 3-kinase.

http://www.wikidata.org/entity/Q30176115

about

Induction of ErbB-3 expression by alpha6beta4 integrin contributes to tamoxifen resistance in ERbeta1-negative breast carcinomas Naturally occurring neomorphic PIK3R1 mutations activate the MAPK pathway, dictating therapeutic response to MAPK pathway inhibitors Lethal congenital contractural syndrome type 2 (LCCS2) is caused by a mutation in ERBB3 (Her3), a modulator of the phosphatidylinositol-3-kinase/Akt pathway What a tangled web we weave: emerging resistance mechanisms to inhibition of the phosphoinositide 3-kinase pathway Regulation of ERBB3/HER3 signaling in cancer Breast tumor cells with PI3K mutation or HER2 amplification are selectively addicted to Akt signaling Heregulin-dependent activation of phosphoinositide 3-kinase and Akt via the ErbB2/ErbB3 co-receptor ErbB4 expression in neural progenitor cells (ST14A) is necessary to mediate neuregulin-1beta1-induced migration Phosphatidylinositol 3-kinase p85{alpha} subunit-dependent interaction with BCR/ABL-related fusion tyrosine kinases: molecular mechanisms and biological consequences.Oscillatory flow-induced proliferation of osteoblast-like cells is mediated by alphavbeta3 and beta1 integrins through synergistic interactions of focal adhesion kinase and Shc with phosphatidylinositol 3-kinase and the Akt/mTOR/p70S6K pathway.Five isoforms of the phosphatidylinositol 3-kinase regulatory subunit exhibit different associations with receptor tyrosine kinases and their tyrosine phosphorylations.Complexity of signal transduction mediated by ErbB2: clues to the potential of receptor-targeted cancer therapy.The role of HER2 in cancer therapy and targeted drug delivery The E3 ubiquitin ligase NEDD4 negatively regulates HER3/ErbB3 level and signaling.ErbB3 expression promotes tumorigenesis in pancreatic adenocarcinoma Receptor tyrosine kinase pathway analysis sheds light on similarities between clear-cell sarcoma and metastatic melanoma.Transcriptional and posttranslational up-regulation of HER3 (ErbB3) compensates for inhibition of the HER2 tyrosine kinase.ErbB3 ablation impairs PI3K/Akt-dependent mammary tumorigenesis.PTEN Loss Is Associated with Worse Outcome in HER2-Amplified Breast Cancer Patients but Is Not Associated with Trastuzumab Resistance.Ansamycin antibiotics inhibit Akt activation and cyclin D expression in breast cancer cells that overexpress HER2.Wnt/Β-catenin and sex hormone signaling in endometrial homeostasis and cancer.Chemopreventive activity of vitamin E in breast cancer: a focus on γ- and δ-tocopherol A critical role for HER3 in HER2-amplified and non-amplified breast cancers: function of a kinase-dead RTK.Pharmacological strategies to overcome HER2 cross-talk and Trastuzumab resistance.Increased erbB3 promotes erbB2/neu-driven mammary tumor proliferation and co-targeting of erbB2/erbB3 receptors exhibits potent inhibitory effects on breast cancer cells Lethal contractural syndrome type 3 (LCCS3) is caused by a mutation in PIP5K1C, which encodes PIPKI gamma of the phophatidylinsitol pathway.Development and characterisation of a 3D multi-cellular in vitro model of normal human breast: a tool for cancer initiation studies Clinical significance of the integrin α6β4 in human malignancies.Heregulin beta1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells.Role of HER2/HER3 co-receptor in breast carcinogenesis.Decreased LRIG1 in fulvestrant-treated luminal breast cancer cells permits ErbB3 upregulation and increased growth.Inhibition of p85, the non-catalytic subunit of phosphatidylinositol 3-kinase, exerts potent antitumor activity in human breast cancer cells.GLI pathogenesis-related 1 functions as a tumor-suppressor in lung cancer Neuregulin-1 enhances survival of human astrocytic glioma cells.Stimulation of beta1-integrin function by epidermal growth factor and heregulin-beta has distinct requirements for erbB2 but a similar dependence on phosphoinositide 3-OH kinase HER3 is required for HER2-induced preneoplastic changes to the breast epithelium and tumor formation.The role of ErbB3 and its binding partners in breast cancer progression and resistance to hormone and tyrosine kinase directed therapies.Trophic factor expression in phrenic motor neurons The ERBB3 receptor in cancer and cancer gene therapy Protein arginine methyltransferase 5 regulates multiple signaling pathways to promote lung cancer cell proliferation

P2860

Q21144348-1C93A3D8-8E5B-4300-BFD9-98624584854C Q24305218-5233F006-3238-4DF3-A07D-15908DE3C13A Q24337544-CFD91E95-F411-4172-B464-44FAB0D94C14 Q26825780-B0D2C906-22BE-4084-8E2E-671600F7ACFC Q27024334-2694B325-4787-4FC3-B5B2-A88AA59EE757 Q27851446-85B1B61F-D71D-417A-9DAC-C9484965740A Q28215701-AE5B67C8-ACAB-4864-B74B-C12D36506A25 Q28578116-386A0DCB-9EBA-4E98-801B-9304E054D35E Q30160146-A056FBB9-92FB-4AA8-B6A3-3525C9F98F7F Q30492711-8156E6EC-2C94-49B1-869A-06EF3621F7F5 Q31924344-62CC5271-BF9E-4890-B2F1-A9F269E70C78 Q33801908-FC80893F-17B0-4BA9-A712-D5CCA56DF7A0 Q34054213-ECDEC554-84A1-48FB-A69F-00E978BA4D99 Q34411756-F37A7713-E4CC-4BEE-A67A-409B07198ECA Q34582105-E54E9D62-90BC-4CB1-A65F-167C45DDAC54 Q34633416-418857CC-F96A-4066-9B57-6492F9456406 Q34720797-55F0F143-FFFE-478A-A7C7-912681B6DFEA Q35479646-3A2EEE44-1A1D-4C42-8538-679F22DEF043 Q35562967-3443F6F4-9E58-4A81-8E97-05A36A5D161A Q35564020-07527C2A-1422-42DD-8120-4215A1F1A9D4 Q35640118-1736EC5F-B55F-4423-8F8B-A34C831DE8BA Q35671133-583E4BD1-8BB9-4542-B11B-B5F06344DF8E Q35682599-EFCD2CCE-7269-4E33-B178-85E14DDD86AA Q35803226-6EDA7376-2441-4644-9A53-8401E6545850 Q35918911-274A5DB6-078F-4BD8-95CC-FDA3080EAD97 Q35946347-435FD0B7-A67F-4015-95FC-F333CA0C9B88 Q35955429-75F88AD1-6ADF-4D07-AAC7-DB87BD08BFE3 Q36010634-34AB1977-1B20-4A3B-838B-58AC13F9DA8B Q36393289-74202593-E663-42C2-BE93-D2B1BD6D90B9 Q36429652-0B77784E-70DF-4714-8DDF-FC1B8C6B020B Q36437261-77616C3D-C0DE-46EA-86BD-373F6EC6A47E Q36525180-41FF70F5-D2FC-42D2-8D45-DDF616E9FAE8 Q36701254-6FB9D02D-A2FD-4D33-9F61-48A1D338A6EE Q36901709-BC01E923-8A2F-4E2A-B989-5F84C7EF6594 Q36907061-0614D9E1-0D19-46AE-A481-758136CE61C7 Q36957145-D0176477-C243-4A3E-8405-1F7B2A2FA2B5 Q37006174-41F8563B-1B02-4075-810D-5ADEC5C00FB0 Q37097654-9BE4ED1A-8886-492B-8478-63EC5AB791D5 Q37135372-7A340963-D606-41A2-9F73-830408070F9B Q37145814-BFD6A95A-373D-4C1A-9AF6-598BAD23D2BD

P2860

ErbB3 (HER3) interaction with the p85 regulatory subunit of phosphoinositide 3-kinase.

http://www.wikidata.org/entity/Q30176115

description

1998 nî lūn-bûn

@nan

1998 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

1998 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

1998年の論文

@ja

1998年論文

@yue

1998年論文

@zh-hant

1998年論文

@zh-hk

1998年論文

@zh-mo

1998年論文

@zh-tw

1998年论文

@wuu

name

ErbB3 (HER3) interaction with the p85 regulatory subunit of phosphoinositide 3-kinase.

@ast

ErbB3 (HER3) interaction with the p85 regulatory subunit of phosphoinositide 3-kinase.

@en

type

label

ErbB3 (HER3) interaction with the p85 regulatory subunit of phosphoinositide 3-kinase.

@ast

ErbB3 (HER3) interaction with the p85 regulatory subunit of phosphoinositide 3-kinase.

@en

prefLabel

ErbB3 (HER3) interaction with the p85 regulatory subunit of phosphoinositide 3-kinase.

@ast

ErbB3 (HER3) interaction with the p85 regulatory subunit of phosphoinositide 3-kinase.

@en

P1433

Q30176115-DE0BB7FF-E374-401A-BD6D-8C8117E6B096

P1476

Q30176115-CACD67F5-F975-4028-97AD-F798C18742AB

P2093

Q30176115-6D0A9FC7-82AA-4FAC-94E9-4998F4789A7B

Q30176115-84ECAA66-E275-48CE-969D-BED9180DD660

P2860

Q30176115-0193FDE0-748A-417B-A0D9-BE8F7C2381FD

Q30176115-02D7904C-9A00-41F6-A88B-7DEE3AD71A06

Q30176115-0BE64498-1910-4F07-9DD5-4A6A069005F2

Q30176115-0D6787E2-1193-4F18-98BD-5C88AC472E71

Q30176115-18BCE591-C15A-4EA4-990A-81886D15D1C5

Q30176115-1EC4D53E-3689-4D14-879A-BBF043569220

Q30176115-20EBDDB8-4E51-488C-8825-3736704B5EE2

Q30176115-242D4223-7022-4648-B944-578E7D8341D4

Q30176115-2895F69B-1847-44C1-A322-EBB080CEDB95

Q30176115-2D33FC51-20B3-4758-865E-5254383ADA31

P304

Q30176115-13E03956-4104-4166-B5E1-AAECB27959D6

P31

Q30176115-C725EACE-94C5-43DE-B93A-4D6A648487C1

P356

Q30176115-8253C97E-AA5B-4811-8DC3-4388A24868D2

P407

Q30176115-6EC7DEF2-35C6-4AAB-A89A-F35F8A1F1A9C

P478

Q30176115-0AB3A9F9-0946-46E5-BA11-3EF7E7C56516

P50

Q30176115-862D9DF3-57E1-4837-ACA0-CDE97CE8ACDC

P577

Q30176115-E0A547BF-B369-4E15-A189-01C2F4A0E430

P5875

Q30176115-D9C7EB10-C317-402E-94D9-4101EF33FB76

P698

Q30176115-2978EE9C-E751-4720-BE58-0BA996CBAE95

P932

Q30176115-CF87D87B-83FB-435A-9BBC-C615D3C55A78

P356

P1433

Biochemical Journal

P1476

ErbB3 (HER3) interaction with the p85 regulatory subunit of phosphoinositide 3-kinase

@en

P2093

K Cheng

http://www.w3.org/2001/XMLSchema#string

N J Hellyer

http://www.w3.org/2001/XMLSchema#string

P2860

The SH3 domain of p56lck is involved in binding to phosphatidylinositol 3'-kinase from T lymphocytes

Spatial constraints on the recognition of phosphoproteins by the tandem SH2 domains of the phosphatase SH-PTP2

Interaction of p85 subunit of PI 3-kinase with insulin and IGF-1 receptors analysed by using the two-hybrid system

Interaction of the molecular weight 85K regulatory subunit of the phosphatidylinositol 3-kinase with the insulin receptor and the insulin-like growth factor-1 (IGF- I) receptor: comparative study using the yeast two-hybrid system

Tandem SH2 binding sites mediate the RasGAP-RhoGAP interaction: a conformational mechanism for SH3 domain regulation

Identification of c-erbB-3 binding sites for phosphatidylinositol 3'-kinase and SHC using an EGF receptor/c-erbB-3 chimera

Direct association of p110 beta phosphatidylinositol 3-kinase with p85 is mediated by an N-terminal fragment of p110 beta

Phosphatidylinositol (PI) 3-kinase and PI 4-kinase binding to the CD4-p56lck complex: the p56lck SH3 domain binds to PI 3-kinase but not PI 4-kinase

Molecular basis for interaction of the protein tyrosine kinase ZAP-70 with the T-cell receptor

A novel genetic system to detect protein-protein interactions

P304

757-763

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1042/BJ3330757

http://www.w3.org/2001/XMLSchema#string

P407

P478

333 ( Pt 3)

http://www.w3.org/2001/XMLSchema#string

P50

P577

1998-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

13608397

http://www.w3.org/2001/XMLSchema#string

P698

9677338

http://www.w3.org/2001/XMLSchema#string

P932

1219642

http://www.w3.org/2001/XMLSchema#string